Related Experiment Video
Updated: Nov 1, 2025

Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers
Mădălina Maria Muntean1,2,3, Andrei-Alexandru Muntean1,2,3, François Guerin4,5
1TeamRESIST, INSERM U1184, School of Medicine, Université Paris-Saclay, LabEx LERMIT, Le Kremlin-Bicêtre, France.
A new rapid Carbapenem Inactivation Method optimized for AmpC producers (rCIM-A) effectively distinguishes between AmpC-hyperproducing Enterobacterales (AHEs) and carbapenemase-producing Enterobacterales (CPEs). This method offers improved specificity for AHEs, making it a valuable tool for accurate CPE detection.
Area of Science:
- Clinical microbiology
- Antimicrobial resistance
- Diagnostic test development
Background:
- Carbapenemase-producing Enterobacterales (CPEs) pose a significant threat due to limited treatment options.
- Distinguishing CPEs from AmpC-hyperproducing Enterobacterales (AHEs) is challenging as AHEs can mimic CPEs in standard tests.
- Accurate and rapid detection methods are crucial for infection control and patient management.
Purpose of the Study:
- To develop and evaluate a modified rapid Carbapenem Inactivation Method (rCIM-A) for accurate differentiation between AHEs and CPEs.
- To assess the performance of rCIM-A compared to the standard rCIM and Carba NP tests.
- To improve the specificity of CPE detection in clinical settings.
Main Methods:
- The study evaluated 249 Enterobacterales isolates, including AHEs, CPEs, and control strains.
- A novel rCIM-A method was developed, incorporating cloxacillin into the initial incubation step of the standard rCIM.
- Performance metrics (sensitivity, specificity) were compared across rCIM-A, rCIM, and Carba NP tests.
Main Results:
- The rCIM-A achieved a sensitivity of 84.26% and a specificity of 99.29% for CPE detection.
- Compared to rCIM (86.11% sensitivity, 80.85% specificity) and Carba NP (84.04% sensitivity, 91.37% specificity), rCIM-A showed significantly improved specificity for AHEs.
- While effective, rCIM-A had limitations in detecting certain carbapenemases like OXA-23 and some MBLs, and one AmpC variant (MIR-10) yielded false positives.
Conclusions:
- The rCIM-A significantly enhances specificity for differentiating AHEs from CPEs without compromising performance for other resistance mechanisms.
- This optimized method is a cheap, easy, rapid, and accurate alternative for CPE detection, potentially replacing the standard rCIM.
- Further refinement may be needed for specific carbapenemase types and certain AmpC variants to ensure comprehensive detection.
More Related Videos
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024